872
Participants
Start Date
March 31, 2011
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
GSK573719/GW642444 125/25
125/25 mcg once-daily
GSK573719/GW642444 62.5/25
62.5/25 mcg once-daily
GSK573719
125 mcg once-daily
tiotropium bromide
18 mcg once-daily
GSK Investigational Site, Boksburg North
GSK Investigational Site, Concord
GSK Investigational Site, Parkville
GSK Investigational Site, Frankston
GSK Investigational Site, Kippa-Ring
GSK Investigational Site, Durban
GSK Investigational Site, Carina Heights
GSK Investigational Site, Cairns
GSK Investigational Site, Adelaide
GSK Investigational Site, Daw Park
GSK Investigational Site, Nedlands
GSK Investigational Site, Gatesville
GSK Investigational Site, Bloemfontein
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, México
GSK Investigational Site, Beaver
GSK Investigational Site, Rüdersdorf
GSK Investigational Site, Schwedt
GSK Investigational Site, Oranienburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Morgantown
GSK Investigational Site, Elizabeth City
GSK Investigational Site, Charlotte
GSK Investigational Site, Spartanburg
GSK Investigational Site, Easley
GSK Investigational Site, Lawrenceville
GSK Investigational Site, Ormond Beach
GSK Investigational Site, Clearwater
GSK Investigational Site, Durango
GSK Investigational Site, Kassel
GSK Investigational Site, Jasper
GSK Investigational Site, Mobile
GSK Investigational Site, Wolfenbüttel
GSK Investigational Site, Madisonville
GSK Investigational Site, Zapopan
GSK Investigational Site, Cincinnati
GSK Investigational Site, Essen
GSK Investigational Site, Essen
GSK Investigational Site, Düren
GSK Investigational Site, Mainz
GSK Investigational Site, Koblenz
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, St Louis
GSK Investigational Site, Aschaffenburg
GSK Investigational Site, Monterrey
GSK Investigational Site, Topeka
GSK Investigational Site, Schwetzingen
GSK Investigational Site, New Orleans
GSK Investigational Site, Lafayette
GSK Investigational Site, Los Angeles
GSK Investigational Site, Huntington Beach
GSK Investigational Site, Medford
GSK Investigational Site, Ploieşti
GSK Investigational Site, Târgovişte
GSK Investigational Site, Constanța
GSK Investigational Site, Talca
GSK Investigational Site, Port Montt
GSK Investigational Site, Santiago
GSK Investigational Site, Santiago
GSK Investigational Site, Santiago
GSK Investigational Site, Santiago
GSK Investigational Site, Santiago
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Ciudad Autonoma de Buenos Aires
GSK Investigational Site, Mendoza
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Winnipeg
GSK Investigational Site, Winnipeg
GSK Investigational Site, Bay Roberts
GSK Investigational Site, Truro
GSK Investigational Site, Greater Sudbury
GSK Investigational Site, Mississauga
GSK Investigational Site, Toronto
GSK Investigational Site, Gatineau
GSK Investigational Site, Québec
GSK Investigational Site, St-Romulad
GSK Investigational Site, Leipzig
GSK Investigational Site, Die Wilgers
GSK Investigational Site, Groenkloof
GSK Investigational Site, Pretoria
GSK Investigational Site, Thabazimbi
GSK Investigational Site, Bucheon-si
GSK Investigational Site, Cheongju, Chungcheongbuk-do
GSK Investigational Site, Daegu
GSK Investigational Site, Incheon
GSK Investigational Site, Incheon
GSK Investigational Site, Kangwon-do
GSK Investigational Site, Seongnam-si, Gyeonggi-do
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Suwon, Kyonggi-do
Lead Sponsor
GlaxoSmithKline
INDUSTRY